Tomorrow's Science For Today's Clinician
As far as the additional dose for the aged with comorbidities is concerned, the guideline insists that the prioritization and sequencing of this ‘precaution dose’ would be based on the completion of 9 months i.e. 39 weeks from the date of administration of 2nd dose and will be given on advice from doctor.
UK, which reported its biggest single-day spike of fresh cases of Covid-19, confirmed that out of the 82,886 fresh cases reported yesterday, 12,133 were Omicron variant.
IMA to campaign about potential risks that diabetics face during the pandemic
The study report stated that across the whole population — including patients older than 65 years, patients who were obese (body-mass index ≥30 kg/m2), and those who had received corticosteroid — IVIG had no effect on the duration of invasive mechanical ventilation and mortality.
Five Indian drugmakers, including Cipla, Dr Reddy’s Laboratories, Sun Pharmaceutical Industries, Torrent Pharmaceuticals and Emcure Pharma, had early this year signed separate non-exclusive voluntary licensing agreements with the inventor Merck Sharp & Dohme (MSD) for manufacturing and marketing this drug locally.
WHO’s Europe chief Hans Kluge warned on Saturday that if Europe and Central Asia stay on the current trajectory of rapid infection and spiralling cases, the regions will see another 5,00,000 Covid related deaths by the first of February, 2022. While, Russia reported a record high 1,195 COVID-related deaths on November 4 amid a surge in new Covid-19 cases.
At least 13,198 patients, who were either hospitalised or under home quarantine, reported recovery on Friday. The country’s total active Covid-19 caseload stands at 1,62,139 as on Friday.
The new lineage of the virus, which is under watch as a Variant Under Investigation (VUI) in the UK after it was found highly contagious and fast moving, has prompted the Indian administration and health experts issuing warnings, reminding that the pandemic’s acute phase is not yet over.
Currently, there are a total of four Indian manufacturers, including Pune-based Serum Institute of India, Hyderababd-based Bharat Biotech and Dr Reddy’s Laboratories, and Ahmedabad-based Zydus Cadila, supplying Covid-19 vaccine in the country.
The crisis proved to be a catalyst for increased adoption of digital healthcare systems across the world. As part of this, India too is undergoing a paradigm shift from the traditional legacy systems to cloud-based applications.